Kras d.d Balance Sheet Health

Financial Health criteria checks 6/6

Kras d.d has a total shareholder equity of €109.7M and total debt of €28.3M, which brings its debt-to-equity ratio to 25.8%. Its total assets and total liabilities are €169.3M and €59.6M respectively. Kras d.d's EBIT is €8.2M making its interest coverage ratio -27.3. It has cash and short-term investments of €19.2M.

Key information

25.8%

Debt to equity ratio

€28.27m

Debt

Interest coverage ratio-27.3x
Cash€19.23m
Equity€109.70m
Total liabilities€59.63m
Total assets€169.33m

Recent financial health updates

Recent updates

What You Can Learn From Kras d.d.'s (ZGSE:KRAS) P/E

Apr 24
What You Can Learn From Kras d.d.'s (ZGSE:KRAS) P/E

Kras d.d (ZGSE:KRAS) Seems To Use Debt Rather Sparingly

Feb 02
Kras d.d (ZGSE:KRAS) Seems To Use Debt Rather Sparingly

Investors Should Be Encouraged By Kras d.d's (ZGSE:KRAS) Returns On Capital

Jul 13
Investors Should Be Encouraged By Kras d.d's (ZGSE:KRAS) Returns On Capital

Statutory Profit Doesn't Reflect How Good Kras d.d's (ZGSE:KRAS) Earnings Are

May 12
Statutory Profit Doesn't Reflect How Good Kras d.d's (ZGSE:KRAS) Earnings Are

Financial Position Analysis

Short Term Liabilities: KRAS's short term assets (€86.6M) exceed its short term liabilities (€35.3M).

Long Term Liabilities: KRAS's short term assets (€86.6M) exceed its long term liabilities (€24.3M).


Debt to Equity History and Analysis

Debt Level: KRAS's net debt to equity ratio (8.2%) is considered satisfactory.

Reducing Debt: KRAS's debt to equity ratio has reduced from 42.5% to 25.8% over the past 5 years.

Debt Coverage: KRAS's debt is well covered by operating cash flow (77.9%).

Interest Coverage: KRAS earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.